cancer

For more cancer news, visit the Vanderbilt-Ingram Cancer Center website »

September 13, 2012

Carmaker’s gift boosts childhood cancer research

Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone.

By Christina Echegaray
August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.

By VUMC News and Communications
August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

By VUMC News and Communications
August 16, 2012

Method may refine personalized trials for cancer therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

By VUMC News and Communications
brain illustration
August 9, 2012

Study links rare genetic marker to brain cancer

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.

By VUMC News and Communications
August 9, 2012

Young patient’s cancer battle inspires hometown

Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer.

By VUMC News and Communications
August 2, 2012

Arteaga named to Komen scientific advisory board

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation.
By VUMC News and Communications
July 26, 2012

Study finds mutation in melanoma sensitive to drug

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.
By VUMC News and Communications
July 20, 2012

High consumption of vitamin E may lower liver cancer risk

By VUMC News and Communications
July 12, 2012

Childhood cancer investigator lands ‘Lemonade Stand’ grant

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer.
By VUMC News and Communications
July 12, 2012

Photo: Living well through cancer

By VUMC News and Communications
July 12, 2012

New cancer drug shows promise in early testing

By VUMC News and Communications
June 22, 2012

Kids’ cells okay after mom’s cancer radiation

Study finds no evidence of increased mitochondrial mutations in the children of women treated with radiation for cancer.
By VUMC News and Communications
1 … 14 15 16 17 18 … 23